Page last updated: 2024-08-24

atorvastatin and Adenoma, Prostatic

atorvastatin has been researched along with Adenoma, Prostatic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anunobi, CC; Dosumu, OO; Ishola, IO; Oshodi, TO; Tijani, HK1
Dong, L; Qu, X; Zeng, X; Zhang, X; Zhao, X1
Crossland, A; Mills, IW; Patel, A; Ramonas, H1
Kaplan, SA1

Trials

2 trial(s) available for atorvastatin and Adenoma, Prostatic

ArticleYear
The effects of statins on benign prostatic hyperplasia in elderly patients with metabolic syndrome.
    World journal of urology, 2015, Volume: 33, Issue:12

    Topics: Age Factors; Aged; Aged, 80 and over; Atorvastatin; C-Reactive Protein; Cholesterol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Male; Metabolic Syndrome; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Simvastatin; Triglycerides

2015
Atorvastatin treatment for men with lower urinary tract symptoms and benign prostatic enlargement.
    European urology, 2007, Volume: 52, Issue:2

    Topics: Aged; Analysis of Variance; Atorvastatin; Double-Blind Method; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Pyrroles; Quality of Life; Treatment Outcome; Urination Disorders

2007

Other Studies

2 other study(ies) available for atorvastatin and Adenoma, Prostatic

ArticleYear
Atorvastatin attenuates testosterone-induced benign prostatic hyperplasia in rats: role of peroxisome proliferator-activated receptor-γ and cyclo-oxygenase-2.
    Fundamental & clinical pharmacology, 2017, Volume: 31, Issue:6

    Topics: Animals; Atorvastatin; Cyclooxygenase 2; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; PPAR gamma; Prostatic Hyperplasia; Random Allocation; Rats; Rats, Wistar; Testosterone

2017
Metabolic dysfunction and male pelvic health.
    European urology, 2007, Volume: 52, Issue:2

    Topics: Atorvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metabolic Syndrome; Prostatic Hyperplasia; Pyrroles; Urination Disorders

2007